1. Home
  2. CHEC vs ANTX Comparison

CHEC vs ANTX Comparison

Compare CHEC & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CHEC

Chenghe Acquisition III Co. Class A Ordinary Share

N/A

Current Price

$10.17

Market Cap

175.5M

Sector

N/A

ML Signal

N/A

Logo AN2 Therapeutics Inc.

ANTX

AN2 Therapeutics Inc.

HOLD

Current Price

$4.51

Market Cap

158.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHEC
ANTX
Founded
2024
2017
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
175.5M
158.8M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
CHEC
ANTX
Price
$10.17
$4.51
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$2.00
AVG Volume (30 Days)
11.8K
412.7K
Earning Date
01-01-0001
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
32.56
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.91
$1.00
52 Week High
$10.56
$6.91

Technical Indicators

Market Signals
Indicator
CHEC
ANTX
Relative Strength Index (RSI) 57.19 47.50
Support Level $10.15 $3.82
Resistance Level $10.47 $5.21
Average True Range (ATR) 0.01 0.39
MACD -0.00 -0.07
Stochastic Oscillator 42.86 29.58

Price Performance

Historical Comparison
CHEC
ANTX

About CHEC Chenghe Acquisition III Co. Class A Ordinary Share

Chenghe Acquisition III Co is blank check company.

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.

Share on Social Networks: